Company / Current Liabilities per Share
InMed Pharmaceuticals Inc. Current Liabilities per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$4.13
FY2025
5-year range
$0.59 / $10.31
FY2022-FY2025
Trend
+596.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +596% YoY in FY2025, a notable deviation from the 3-year average annual change of +149%.
Based on SEC 10-K filings.
4.13 in FY2025 with a 3-year CAGR of -26.3%.
Increased from $3.07 to $4.13 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -26.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 596.4% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.13 | +596.4% |
| FY2024 | $0.59 | -80.7% |
| FY2023 | $3.07 | -70.2% |
| FY2022 | $10.31 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026